. LillyPad Avidity to Partner on Immunology Drugs in Upto$440M Collaboration httpow.lygJNH30ov41RÂpic.twitter.comGw7y1hPZQq

. @LillyPad, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration: http://ow.ly/gJNH30ov41R pic.twitter.com/Gw7y1hPZQq

12:25 EDT 27 Apr 2019 | Genetic Engineering News

. @LillyPad, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration: http://ow.ly/gJNH30ov41R  pic.twitter.com/Gw7y1hPZQq

More From BioPortfolio on ". @LillyPad, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration: http://ow.ly/gJNH30ov41R pic.twitter.com/Gw7y1hPZQq"